Copyright Reports & Markets. All rights reserved.

Global Femoral Arterial Cannulae Market Research Report 2021

Request for Sample of this report
Buy now

1 Femoral Arterial Cannulae Market Overview

  • 1.1 Product Overview and Scope of Femoral Arterial Cannulae
  • 1.2 Femoral Arterial Cannulae Segment by Type
    • 1.2.1 Global Femoral Arterial Cannulae Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Unipolar Femoral Arterial Cannulae
    • 1.2.3 Bipolar Femoral Arterial Cannulae
  • 1.3 Femoral Arterial Cannulae Segment by Application
    • 1.3.1 Femoral Arterial Cannulae Sales Comparison by Application: (2021-2027)
    • 1.3.2 Traditional cardiopulmonary bypass surgery
    • 1.3.3 Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
    • 1.3.4 Hemodialysis
    • 1.3.5 other
  • 1.4 Global Femoral Arterial Cannulae Market Size Estimates and Forecasts
    • 1.4.1 Global Femoral Arterial Cannulae Revenue 2016-2027
    • 1.4.2 Global Femoral Arterial Cannulae Sales 2016-2027
    • 1.4.3 Femoral Arterial Cannulae Market Size by Region: 2016 Versus 2021 Versus 2027

2 Femoral Arterial Cannulae Market Competition by Manufacturers

  • 2.1 Global Femoral Arterial Cannulae Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Femoral Arterial Cannulae Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Femoral Arterial Cannulae Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Femoral Arterial Cannulae Manufacturing Sites, Area Served, Product Type
  • 2.5 Femoral Arterial Cannulae Market Competitive Situation and Trends
    • 2.5.1 Femoral Arterial Cannulae Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Femoral Arterial Cannulae Players Market Share by Revenue
    • 2.5.3 Global Femoral Arterial Cannulae Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Femoral Arterial Cannulae Retrospective Market Scenario by Region

  • 3.1 Global Femoral Arterial Cannulae Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Femoral Arterial Cannulae Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Femoral Arterial Cannulae Market Facts & Figures by Country
    • 3.3.1 North America Femoral Arterial Cannulae Sales by Country
    • 3.3.2 North America Femoral Arterial Cannulae Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Femoral Arterial Cannulae Market Facts & Figures by Country
    • 3.4.1 Europe Femoral Arterial Cannulae Sales by Country
    • 3.4.2 Europe Femoral Arterial Cannulae Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Femoral Arterial Cannulae Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Femoral Arterial Cannulae Sales by Region
    • 3.5.2 Asia Pacific Femoral Arterial Cannulae Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Femoral Arterial Cannulae Market Facts & Figures by Country
    • 3.6.1 Latin America Femoral Arterial Cannulae Sales by Country
    • 3.6.2 Latin America Femoral Arterial Cannulae Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Femoral Arterial Cannulae Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Femoral Arterial Cannulae Sales by Country
    • 3.7.2 Middle East and Africa Femoral Arterial Cannulae Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Femoral Arterial Cannulae Historic Market Analysis by Type

  • 4.1 Global Femoral Arterial Cannulae Sales Market Share by Type (2016-2021)
  • 4.2 Global Femoral Arterial Cannulae Revenue Market Share by Type (2016-2021)
  • 4.3 Global Femoral Arterial Cannulae Price by Type (2016-2021)

5 Global Femoral Arterial Cannulae Historic Market Analysis by Application

  • 5.1 Global Femoral Arterial Cannulae Sales Market Share by Application (2016-2021)
  • 5.2 Global Femoral Arterial Cannulae Revenue Market Share by Application (2016-2021)
  • 5.3 Global Femoral Arterial Cannulae Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Medtronic
    • 6.1.1 Medtronic Corporation Information
    • 6.1.2 Medtronic Description and Business Overview
    • 6.1.3 Medtronic Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Medtronic Product Portfolio
    • 6.1.5 Medtronic Recent Developments/Updates
  • 6.2 Edward Lifescience
    • 6.2.1 Edward Lifescience Corporation Information
    • 6.2.2 Edward Lifescience Description and Business Overview
    • 6.2.3 Edward Lifescience Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Edward Lifescience Product Portfolio
    • 6.2.5 Edward Lifescience Recent Developments/Updates
  • 6.3 LivaNova
    • 6.3.1 LivaNova Corporation Information
    • 6.3.2 LivaNova Description and Business Overview
    • 6.3.3 LivaNova Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 LivaNova Product Portfolio
    • 6.3.5 LivaNova Recent Developments/Updates
  • 6.4 Surge Cardiovascular
    • 6.4.1 Surge Cardiovascular Corporation Information
    • 6.4.2 Surge Cardiovascular Description and Business Overview
    • 6.4.3 Surge Cardiovascular Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Surge Cardiovascular Product Portfolio
    • 6.4.5 Surge Cardiovascular Recent Developments/Updates
  • 6.5 Kangxin Medical
    • 6.5.1 Kangxin Medical Corporation Information
    • 6.5.2 Kangxin Medical Description and Business Overview
    • 6.5.3 Kangxin Medical Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Kangxin Medical Product Portfolio
    • 6.5.5 Kangxin Medical Recent Developments/Updates
  • 6.6 Charlice Medical
    • 6.6.1 Charlice Medical Corporation Information
    • 6.6.2 Charlice Medical Description and Business Overview
    • 6.6.3 Charlice Medical Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Charlice Medical Product Portfolio
    • 6.6.5 Charlice Medical Recent Developments/Updates
  • 6.7 Xenios AG
    • 6.6.1 Xenios AG Corporation Information
    • 6.6.2 Xenios AG Description and Business Overview
    • 6.6.3 Xenios AG Femoral Arterial Cannulae Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Xenios AG Product Portfolio
    • 6.7.5 Xenios AG Recent Developments/Updates

7 Femoral Arterial Cannulae Manufacturing Cost Analysis

  • 7.1 Femoral Arterial Cannulae Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Femoral Arterial Cannulae
  • 7.4 Femoral Arterial Cannulae Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Femoral Arterial Cannulae Distributors List
  • 8.3 Femoral Arterial Cannulae Customers

9 Femoral Arterial Cannulae Market Dynamics

  • 9.1 Femoral Arterial Cannulae Industry Trends
  • 9.2 Femoral Arterial Cannulae Growth Drivers
  • 9.3 Femoral Arterial Cannulae Market Challenges
  • 9.4 Femoral Arterial Cannulae Market Restraints

10 Global Market Forecast

  • 10.1 Femoral Arterial Cannulae Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Femoral Arterial Cannulae by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Femoral Arterial Cannulae by Type (2022-2027)
  • 10.2 Femoral Arterial Cannulae Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Femoral Arterial Cannulae by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Femoral Arterial Cannulae by Application (2022-2027)
  • 10.3 Femoral Arterial Cannulae Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Femoral Arterial Cannulae by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Femoral Arterial Cannulae by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Unipolar Femoral Arterial Cannulae
    Bipolar Femoral Arterial Cannulae

    Segment by Application
    Traditional cardiopulmonary bypass surgery
    Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
    Hemodialysis
    other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Medtronic
    Edward Lifescience
    LivaNova
    Surge Cardiovascular
    Kangxin Medical
    Charlice Medical
    Xenios AG

    Buy now